Cholinergic Innervation and Muscarinic Receptors in the Human Prostate

European Urology

Volumn 54, Issue 2, 2008, Pages 326-334

  Witte, Lambertus P W ^a   Chapple, Christopher R ^b   de la Rosette, Jean J M C H ^a   Michel, Martin C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Contraction; Muscarinic receptors; Parasympathetic nerves; Proliferation; Prostate

Indexed keywords

CHOLINERGIC RECEPTOR; CYCLIC AMP; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT;

BLADDER CONTRACTION; CALCIUM CELL LEVEL; CANCER CELL; DRUG MECHANISM; EPITHELIUM CELL; HUMAN; LOWER URINARY TRACT SYMPTOM; MUSCLE CONTRACTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE SECRETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STROMA CELL;

CHOLINERGIC FIBERS; HUMANS; MALE; PROSTATE; RECEPTORS, MUSCARINIC;

EID: 45849132061     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.12.007     Document Type: Review

References (55)

1. Chapple C., Khullar V., Gabriel Z., and Dooley J.A. The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis. Eur Urol 48 (2005) 5-26 Corrigendum. Eur Urol 2005;48:875
2. Herbison P., Hay-Smith J., Ellis G., and Moore K. Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. Br Med J 326 (2003) 841-844
3. Barendrecht M.M., Oelke M., Laguna M.P., and Michel M.C. Is the use of parasympathomimetics for treating an underactive urinary bladder evidence-based?. BJU Int 99 (2007) 749-752
4. Abrams P., Kaplan S., de Koning Gans H.J., and Millard R. Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction. J Urol 175 (2006) 999-1004
5. Kaplan S.A., Roehrborn C.G., Rovner E.S., Carlsson M., Bavendamm T., and Guan Z. Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder. A randomized controlled trial. JAMA 296 (2006) 2319-2328
6. Lee J.Y., Kim H.W., Lee S.J., Koh J.S., Suh H.J., and Chancellor M.B. Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder. BJU Int 94 (2004) 817-820
7. Lee K.-S., Choo M.-S., Kim D.-Y., et al. Combination treatment with propiverine hydrochloride plus doxazosin controlled release gastrointestinal therapeutic system formulation for overactive bladder and coexisting benign prostatic obstruction: a prospective, randomized, controlled multicenter study. J Urol 174 (2005) 1334-1338
8. Maruyama O., Kawachi Y., Hanazawa K., et al. Naftopidil monotherapy vs naftopidil and an anticholinergic agent combined therapy for storage symptoms associated with benign prostatic hyperplasia: a prospective randomized controlled study. Int J Urol 13 (2006) 1280-1285
9. Yang Y., Zhao X., Li H., et al. Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study. Chin Med J 120 (2007) 370-374
10. Chapple C.R., and Roehrborn C.G. A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder. Eur Urol 49 (2006) 651-659
11. Ventura S., Pennefather J.N., and Mitchelson F. Cholinergic innervation and function in the prostate gland. Pharmacol Ther 94 (2002) 93-112
12. Caulfield M.P., and Birdsall N.J.M. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 50 (1998) 279-290
13. Abrams P., Andersson K.-E., Buccafusco J.J., et al. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol 148 (2006) 565-578
14. Hegde S.S. Muscarinic receptors in the bladder: from basic research to therapeutics. Br J Pharmacol 147 (2006) S80-S87
15. Pennefather J.N., Lau W.A.K., Mitchelson F., and Ventura S. The autonomic and sensory innervation of the smooth muscle of the prostate gland: a review of pharmacological and histological studies. J Auton Pharmacol 20 (2000) 193-206
16. Casas A.P. Die Innervation der männlichen Vorsteherdrüse. Z Mikrosk Anat Forsch 64 (1958) 608-633
17. Görg A., and Werner S. Lichtmikroskopische und elektronenoptische Studien zur normalen und pathologischen Histologie der Prostata unter besonderer Berücksichtigung des Nervensystems. Acta Neuroveg (Wien) 29 (1966) 203-219
18. Crowe R., Chapple C.R., and Burnstock G. The human prostate gland: a histochemical and immunohistochemical study of neuropeptides, serotonin, dopamine β-hydroxylase and acetylcholinesterase in autonomic nerves and ganglia. Br J Urol 68 (1991) 53-61
19. Klück P. The autonomic innervation of the human urinary bladder, bladder neck and urethra: a histochemical study. Anat Rec 198 (1980) 439-447
20. Dixon J.S., Jen P.Y.P., and Gosling J.A. The distribution of vesicular acetylcholine transporter in the human male genitourinary organs and its co-localization with neuropeptide Y and nitric oxide sytnhase. Neurourol Urodyn 19 (2000) 185-194
21. Gosling J.A., and Thompson S.A. A neurohistochemical and histological study of peripheral autonomic neurons of the human bladder neck and prostate. Urol Int 32 (1977) 269-276
22. Dunzendorfer U., Jonas D., and Weber W. The autonomic innervation of the human prostate. Histochemistry of acetylcholinesterase in the normal and pathologic states. Urol Res 4 (1976) 29-31
23. Vaalasti A., and Hervonen A. Autonomic innervation of the human prostate. Invest Urol 17 (1980) 293-297
24. Crowe R., Chapple C.R., Milroy E.J.G., Turner-Warwick R.T., and Burnstock G. Peptide, amine and enzyme-containing autonomic ganglia and nerve fibres in the human prostate gland. Neurourol Urodyn 7 (1988) 166-167
25. Higgins J.R.A., and Gosling J.A. Studies on the structure and intrinsic innervation of the normal human prostate. Prostate Suppl 2 (1989) 5-16
26. Hedlund P., Ekström P., Larsson B., Alm P., and Andersson K.-E. Heme oxygenase and NO-synthase in the human prostate-relation to adrenergic, cholinergic and peptide-containing nerves. J Auton Nerv System 63 (1997) 115-126
27. Gosling JA. Autonomic innervation of the prostate. In: Benign Prostatic Hypertrophy. Edited by F. Hinman Jr. Springer Verlag, Berlin. 1983; p. 349-60.
28. Obara K., Arai K., Miyajima N., Hatano A., Tomita Y., and Takahashi K. Expression of m2 muscarinic acetylcholine receptor mRNA in primary culture of human prostate stromal cells. Urol Res 28 (2000) 196-200
29. Goepel M., Gronewald A., Krege S., and Michel M.C. Muscarinic receptor subtypes in porcine detrusor: comparison with humans and regulation by bladder augmentation. Urol Res 26 (1998) 149-154
30. Lepor H., and Kuhar M.J. Characterization and localization of the muscarinic cholinergic receptor in human prostatic tissue. J Urol 132 (1984) 397-402
31. Lepor H., Gup D.I., Baumann M., and Shapiro E. Laboratory assessment of terazosin and alpha-1 blockade in prostatic hyperplasia. Urology 32 Suppl (1988) 21-26
32. Gup D.I., Shapiro E., Baumann M., and Lepor H. Autonomic receptors in human prostate adenomas. J Urol 143 (1990) 179-185
33. Hedlund H., Andersson K.-E., and Larsson B. Alpha-adrenoceptors and muscarinic receptors in the isolated human prostate. J Urol 134 (1985) 1291-1298
34. Ruggieri M.R., Colton M.D., Wang P., et al. Human prostate muscarinic receptor subtypes. J Pharmacol Exp Ther 274 (1995) 976-982
35. James S., Chapple C.R., Phillips M.I., et al. Autoradiographic analysis of alpha-adrenoceptors and muscarinic cholinergic receptors in the hyperplastic human prostate. J Urol 142 (1989) 438-444
36. Yazawa H., Saita Y., Iida E., Honma Y., Morita T., and Honda K. Characterization of muscarinic cholinoceptor in primary culture of smooth muscle cells from human prostate. J Urol 152 (1994) 2173-2177
37. 2- and β-adrenoceptors in the urinary bladder, urethra and prostate. Br J Pharmacol 147 (2006) S88-S119
38. Schneider T., Fetscher C., Krege S., and Michel M.C. Signal transduction underlying carbachol-induced contraction of human urinary bladder. J Pharmacol Exp Ther 309 (2004) 1148-1153
39. Schmidt M., Bienek C., van Koppen C.J., Michel M.C., and Jakobs K.H. Differential calcium signalling by m2 and m3 muscarinic acetylcholine receptors in a single cell type. Naunyn Schmiedeberg Arch Pharmacol 352 (1995) 469-476
40. Patel M.K., Schachter M., and Sever P.S. Muscarinic receptors of human prostatic stromal cells in vitro. Eur J Pharmacol 183 (1990) 1992 (abstract)
41. Drescher P., Eckert R.E., and Madsen P.O. Smooth muscle contractility in prostatic hyperplasia: role of cyclic adenosine monophosphate. Prostate 25 (1994) 76-80
42. Macht D.I. Physiological and pharmacological studies of the prostate gland. IV. Response of prostatic muscle to drugs. J Urol 7 (1922) 407-415
43. Caine M., Raz S., and Zeigler M. Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck. Br J Urol 47 (1975) 193-202
44. Gup D.I., Shapiro E., Baumann M., and Lepor H. Contractile properties of human prostate adenomas and the development of infravesical obstruction. Prostate 15 (1989) 105-114
45. Kester R.R., Mooppan U.M.M., Gousse A.E., et al. Pharmacological characterization of isolated human prostate. J Urol 170 (2003) 1032-1038
46. Najbar-Kaszkiel A.T., Di Iulio J.L., Li C.G., and Rand M.J. Characterisation of excitatory and inhibitory transmitter systems in prostate glands of rats, guinea pigs, rabbits and pigs. Eur J Pharmacol 337 (1997) 251-258
47. Lau W.A.K., Pennefather J.N., and Mitchelson F.J. Cholinergic facilitation of neurotransmission to the smooth muscle of the guinea-pig prostate gland. Br J Pharmacol 130 (2000) 1013-1020
48. Bruschini H., Schmidt R.A., and Tanagho E.A. Neurologic control of prostatic secretion in the dog. Invest Urol 15 (1978) 288-290
49. Rayford W., Noble M.J., Austenfeld M.A., Weigl J., Mebust W.K., and Shah G.V. Muscarinic cholinergic receptors promote growth of human prostate cancer cells. Prostate 30 (1997) 160-166
50. Luthin G.R., Wang P., Zhou H., Dhanasekaran D., and Ruggieri M.R. Role of m1 receptor-G protein coupling in cell proliferation in the prostate. Life Sci 60 (1997) 963-968
51. Chuang Y.-C., Huang C.-C., Kang H.-Y., et al. Novel action of botulinum toxin on the stromal and epithelial components of the prostate gland. J Urol 175 (2006) 1158-1163
52. Chuang Y.-C., Tu C.-H., Huang C.-C., et al. Intraprostatic injection of botulinum toxin type-A relieves bladder outlet obstruction in human and induces prostate apoptosis in dogs. BMC Urol 6 (2006) 12
53. Chapple C.R., Crowe R., Gilpin S.A., Gosling J., and Burnstock G. The innervation of the human prostate gland-the changes associated with benign enlargement. J Urol 146 (1991) 1637-1644
54. Blanco M., and Robinson M.J. Muscarinic M3 acetylcholine receptor immunostaining in paraffin-embedded normal and neoplastic prostatic gland tissue. Ann Diagn Pathol 8 (2004) 333-336
55. Novara G., Galfano A., Ficarra V., and Artibani W. Anticholinergic drugs in patients with bladder outlet obstruction and lower urinary tract symptoms: a systematic review. Eur Urol 50 (2006) 675-683